WADA has been publishing an annual List of Prohibited Substances and Methods (List) since 2004, as mandated by World Anti-Doping Code (Code). The List, which forms one of the eight International Standards, identifies the substances and methods prohibited in- and out-of-competition, and in particular sports.
WADA’s role, through its List Expert Advisory Group and Health, Medical and Research Committee, is to facilitate a consultation period before preparing and publishing the List by 1 October in order to allow for its introduction at the start of the following year.
Stakeholder can raise issues and comments they have regarding the List. All comments received are considered and discussed in detail at List Expert Advisory Group meetings.
With each new addition of the List, WADA publishes the Summary of Modifications and Explanatory Notes with further information.
The 2023 List of Prohibited Substances and Methods came into effect on 1 January 2023.
WADA, in consultation with Signatories and governments, establishes a monitoring program regarding substances which are not on the Prohibited List, but which WADA wishes to monitor in order to detect patterns of misuse in sport.
WADA publishes, in advance of any testing, the substances that will be monitored. Laboratories will report the instances of reported use or detected presence of these substances to WADA periodically on an aggregate basis by sport and whether the samples were collected in-competition or out–of-competition. These reports do not contain additional information regarding specific samples.
WADA makes aggregate statistical information by sport regarding the additional substances available to Anti-Doping Organizations (ADOs), on at least an annual basis. WADA implements measures to ensure that strict anonymity of individual athletes is maintained with respect to such reports. The reported use or detected presence of a monitored substance shall not constitute an Anti-Doping Rule Violation (ADRV).